Articles in this issue

• 

  Navigating nuanced CGT clinical trial logistics

  Wednesday, June 11, 2025
  Advances in interactive response technology platforms for drug supply can be highly beneficial when thoughtfully designed to address the unique challenges of CGT trials. This is especially true when ... read more
• 

  Optimizing seed train processes

  Monday, June 02, 2025
  As the CGT space grows, making therapies available to more patients will require an all-encompassing approach to improving efficiency to lower manufacturing costs. New seed train technologies can not ... read more
• 

  Precision logistics for complex therapies

  Wednesday, May 28, 2025
  Patient-specific therapies come with unique logistics that bring added complexity and risk to supply chains. Manufacturing these therapies will continue to require robust supply chain management, ... read more
• 

  Overcoming CGT starting material challenges

  Wednesday, May 21, 2025
  Much of the focus for making CGTs accessible and commercially viable has looked downstream at manufacturing, logistics, geography, centralization, and even intellectual property. However, the vast ... read more
• 

  Shooting for immune

  Tuesday, May 13, 2025
  While it is still early days for CGTs in autoimmune disease, the field is actively pushing its own limits, working to translate scientific excitement into better, more accessible products. Not only ... read more
• 

  Above the noise: CGT developers focus on access to better treatments amid immunology boom

  Monday, May 05, 2025
  The urgency of unmet need has not evaded the CGT sector, which has executed a ‘strategic pivot’ into autoimmune disease. Developers with B-cell targeting therapies originally designed to detect and ... read more
• 

  From bispecifics and ADCs to better reagents

  Wednesday, April 30, 2025
  Advances have allowed for the creation of bispecific, ‘Fc-silenced,’ and other specialized antibody reagents tailored to specific research needs. These engineered antibodies are deepening our ... read more